AAPL333.08+0.81 (+0.24%) ▲|ABBV261.77+4.65 (+1.81%) ▲|ABT103.09+1.14 (+1.12%) ▲|ACN195.00+11.10 (+6.04%) ▲|ADBE265.60+13.37 (+5.30%) ▲|AMAT424.21-32.28 (-7.07%) ▼|AMD493.41-22.72 (-4.40%) ▼|AMGN381.50+4.15 (+1.10%) ▲|AMT176.94-0.91 (-0.51%) ▼|AMZN253.54-3.24 (-1.26%) ▼|AVGO344.72-17.27 (-4.77%) ▼|AXP327.78+3.09 (+0.95%) ▲|BA210.27-0.18 (-0.09%) ▼|BAC59.47-3.22 (-5.14%) ▼|BKNG175.35+1.43 (+0.82%) ▲|BLK1,065.60-14.05 (-1.30%) ▼|BMY64.10+0.46 (+0.72%) ▲|BNY157.66-5.00 (-3.07%) ▼|BRK-B514.95+4.58 (+0.90%) ▲|C136.18-2.64 (-1.90%) ▼|CAT784.00-34.57 (-4.22%) ▼|CL87.89+1.09 (+1.26%) ▲|CMCSA24.88-0.32 (-1.27%) ▼|COF206.68-1.62 (-0.78%) ▼|COP136.67-0.68 (-0.50%) ▼|COST918.91+14.14 (+1.56%) ▲|CRM259.43+11.71 (+4.73%) ▲|CSCO110.06-2.07 (-1.85%) ▼|CVS95.55+0.89 (+0.94%) ▲|CVX212.17-1.89 (-0.88%) ▼|DE681.46+5.72 (+0.85%) ▲|DHR203.25+3.11 (+1.55%) ▲|DIS108.59+2.04 (+1.91%) ▲|DUK119.02-0.40 (-0.34%) ▼|EMR148.30-3.89 (-2.56%) ▼|FDX312.57+1.80 (+0.58%) ▲|GD356.81+0.91 (+0.26%) ▲|GE317.56-6.10 (-1.88%) ▼|GEV874.76-82.51 (-8.62%) ▼|GILD146.41+2.69 (+1.87%) ▲|GM87.16+1.54 (+1.80%) ▲|GOOG345.71+10.26 (+3.06%) ▲|GOOGL349.39+10.89 (+3.22%) ▲|GS988.45-40.73 (-3.96%) ▼|HD310.87+2.13 (+0.69%) ▲|HON201.38-0.98 (-0.48%) ▼|IBM249.09+5.80 (+2.38%) ▲|INTC97.19-5.75 (-5.59%) ▼|INTU339.15+17.58 (+5.47%) ▲|ISRG377.94+8.79 (+2.38%) ▲|JNJ266.32+0.74 (+0.28%) ▲|JPM350.13-6.10 (-1.71%) ▼|KO89.35+1.06 (+1.20%) ▲|LIN464.41-1.81 (-0.39%) ▼|LLY1,138.28+22.58 (+2.02%) ▲|LMT529.38+5.19 (+0.99%) ▲|LOW198.17+1.35 (+0.69%) ▲|LRCX273.49-24.73 (-8.29%) ▼|MA574.42+5.23 (+0.92%) ▲|MCD257.49+4.96 (+1.96%) ▲|MDLZ62.39-0.05 (-0.08%) ▼|MDT93.80+2.84 (+3.12%) ▲|META665.60+17.57 (+2.71%) ▲|MMM162.02-2.95 (-1.79%) ▼|MO70.61+1.63 (+2.36%) ▲|MRK144.85+0.92 (+0.64%) ▲|MS206.58-7.80 (-3.64%) ▼|MSFT505.41+9.78 (+1.97%) ▲|MU924.03-51.23 (-5.25%) ▼|NEE81.63-0.68 (-0.83%) ▼|NFLX80.32+2.92 (+3.77%) ▲|NKE37.05+0.25 (+0.68%) ▲|NOW142.35+9.82 (+7.41%) ▲|NVDA210.96-7.33 (-3.36%) ▼|ORCL144.79-5.49 (-3.65%) ▼|PEP136.34+0.02 (+0.01%) ▲|PFE27.72+0.00 (+0.00%) ▲|PG146.13+0.86 (+0.59%) ▲|PLTR173.31+6.08 (+3.64%) ▲|PM194.86+3.80 (+1.99%) ▲|QCOM180.15-1.82 (-1.00%) ▼|RTX195.34-2.34 (-1.18%) ▼|SBUX99.07+0.33 (+0.33%) ▲|SCHW107.31+0.06 (+0.06%) ▲|SO87.00-0.17 (-0.20%) ▼|SPG204.97+0.14 (+0.07%) ▲|T26.51+0.45 (+1.73%) ▲|TMO613.62+3.80 (+0.62%) ▲|TMUS182.90+0.57 (+0.31%) ▲|TSLA358.97-6.47 (-1.77%) ▼|TXN263.42-5.28 (-1.97%) ▼|UBER72.63+0.96 (+1.34%) ▲|UNH383.55+6.78 (+1.80%) ▲|UNP285.08+0.68 (+0.24%) ▲|UPS102.46+2.18 (+2.17%) ▲|USB62.68-0.16 (-0.25%) ▼|V375.28+4.83 (+1.30%) ▲|VZ51.29+0.68 (+1.34%) ▲|WFC88.71-1.58 (-1.75%) ▼|WMT109.08+1.93 (+1.80%) ▲|XOM165.08-0.91 (-0.55%) ▼|AAPL333.08+0.81 (+0.24%) ▲|ABBV261.77+4.65 (+1.81%) ▲|ABT103.09+1.14 (+1.12%) ▲|ACN195.00+11.10 (+6.04%) ▲|ADBE265.60+13.37 (+5.30%) ▲|AMAT424.21-32.28 (-7.07%) ▼|AMD493.41-22.72 (-4.40%) ▼|AMGN381.50+4.15 (+1.10%) ▲|AMT176.94-0.91 (-0.51%) ▼|AMZN253.54-3.24 (-1.26%) ▼|AVGO344.72-17.27 (-4.77%) ▼|AXP327.78+3.09 (+0.95%) ▲|BA210.27-0.18 (-0.09%) ▼|BAC59.47-3.22 (-5.14%) ▼|BKNG175.35+1.43 (+0.82%) ▲|BLK1,065.60-14.05 (-1.30%) ▼|BMY64.10+0.46 (+0.72%) ▲|BNY157.66-5.00 (-3.07%) ▼|BRK-B514.95+4.58 (+0.90%) ▲|C136.18-2.64 (-1.90%) ▼|CAT784.00-34.57 (-4.22%) ▼|CL87.89+1.09 (+1.26%) ▲|CMCSA24.88-0.32 (-1.27%) ▼|COF206.68-1.62 (-0.78%) ▼|COP136.67-0.68 (-0.50%) ▼|COST918.91+14.14 (+1.56%) ▲|CRM259.43+11.71 (+4.73%) ▲|CSCO110.06-2.07 (-1.85%) ▼|CVS95.55+0.89 (+0.94%) ▲|CVX212.17-1.89 (-0.88%) ▼|DE681.46+5.72 (+0.85%) ▲|DHR203.25+3.11 (+1.55%) ▲|DIS108.59+2.04 (+1.91%) ▲|DUK119.02-0.40 (-0.34%) ▼|EMR148.30-3.89 (-2.56%) ▼|FDX312.57+1.80 (+0.58%) ▲|GD356.81+0.91 (+0.26%) ▲|GE317.56-6.10 (-1.88%) ▼|GEV874.76-82.51 (-8.62%) ▼|GILD146.41+2.69 (+1.87%) ▲|GM87.16+1.54 (+1.80%) ▲|GOOG345.71+10.26 (+3.06%) ▲|GOOGL349.39+10.89 (+3.22%) ▲|GS988.45-40.73 (-3.96%) ▼|HD310.87+2.13 (+0.69%) ▲|HON201.38-0.98 (-0.48%) ▼|IBM249.09+5.80 (+2.38%) ▲|INTC97.19-5.75 (-5.59%) ▼|INTU339.15+17.58 (+5.47%) ▲|ISRG377.94+8.79 (+2.38%) ▲|JNJ266.32+0.74 (+0.28%) ▲|JPM350.13-6.10 (-1.71%) ▼|KO89.35+1.06 (+1.20%) ▲|LIN464.41-1.81 (-0.39%) ▼|LLY1,138.28+22.58 (+2.02%) ▲|LMT529.38+5.19 (+0.99%) ▲|LOW198.17+1.35 (+0.69%) ▲|LRCX273.49-24.73 (-8.29%) ▼|MA574.42+5.23 (+0.92%) ▲|MCD257.49+4.96 (+1.96%) ▲|MDLZ62.39-0.05 (-0.08%) ▼|MDT93.80+2.84 (+3.12%) ▲|META665.60+17.57 (+2.71%) ▲|MMM162.02-2.95 (-1.79%) ▼|MO70.61+1.63 (+2.36%) ▲|MRK144.85+0.92 (+0.64%) ▲|MS206.58-7.80 (-3.64%) ▼|MSFT505.41+9.78 (+1.97%) ▲|MU924.03-51.23 (-5.25%) ▼|NEE81.63-0.68 (-0.83%) ▼|NFLX80.32+2.92 (+3.77%) ▲|NKE37.05+0.25 (+0.68%) ▲|NOW142.35+9.82 (+7.41%) ▲|NVDA210.96-7.33 (-3.36%) ▼|ORCL144.79-5.49 (-3.65%) ▼|PEP136.34+0.02 (+0.01%) ▲|PFE27.72+0.00 (+0.00%) ▲|PG146.13+0.86 (+0.59%) ▲|PLTR173.31+6.08 (+3.64%) ▲|PM194.86+3.80 (+1.99%) ▲|QCOM180.15-1.82 (-1.00%) ▼|RTX195.34-2.34 (-1.18%) ▼|SBUX99.07+0.33 (+0.33%) ▲|SCHW107.31+0.06 (+0.06%) ▲|SO87.00-0.17 (-0.20%) ▼|SPG204.97+0.14 (+0.07%) ▲|T26.51+0.45 (+1.73%) ▲|TMO613.62+3.80 (+0.62%) ▲|TMUS182.90+0.57 (+0.31%) ▲|TSLA358.97-6.47 (-1.77%) ▼|TXN263.42-5.28 (-1.97%) ▼|UBER72.63+0.96 (+1.34%) ▲|UNH383.55+6.78 (+1.80%) ▲|UNP285.08+0.68 (+0.24%) ▲|UPS102.46+2.18 (+2.17%) ▲|USB62.68-0.16 (-0.25%) ▼|V375.28+4.83 (+1.30%) ▲|VZ51.29+0.68 (+1.34%) ▲|WFC88.71-1.58 (-1.75%) ▼|WMT109.08+1.93 (+1.80%) ▲|XOM165.08-0.91 (-0.55%) ▼|
20.9 C
New York
Tuesday, September 15, 2026

Tag: launch

2U and Oxford Saïd Business School Expand Partnership with Launch of New Executive AI Programme and First-Ever Open Courses on edX

Partnership now includes nearly 40 programmes in high-demand topics across flexible formats—from foundational online learning to advanced executive education ARLINGTON, Va. and OXFORD, England, July...

Corlines kund Kardium genomför finansiering om 250 miljoner USD för lanseringen av Globe®

Kanadensiska Kardium meddelade under dagen att man genomfört en kapitalrekrytering om 250 miljoner USD för att stödja global kommersialisering av Globe® Pulsed Field System – en banbrytande plattform för behandling av förmaksflimmer med hjälp av behandlingstekniken pulsed field ablation (PFA). Den nu kommunicerade investeringen innebär att Kardium sammantaget attraherat över 350 miljoner USD från externa investerare under de senaste dryga tolv månaderna, vilket tillhör det absoluta toppskiktet i den nordamerikanska medicinteknikindustrin.

Montana Silversmiths Unveils Expansive July Product Drop, Celebrating American Craftsmanship

COLUMBUS, Mont., July 2, 2025 /PRNewswire/ -- Montana Silversmiths, the iconic country and western apparel brand renowned for its exquisite buckles and jewelry, is thrilled...

Highest THCa Flower July 2025: New Hemp Hop Strains Hit the Market

Hemp Hop launches the Best THCa flower strains of July 2025 with London Jealousy and Gravel Pit, known for premium quality and high THCa content.

Enphase Energy Launches Next-Generation IQ EV Charger 2 In Australia and New Zealand

FREMONT, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced production shipments of its newest electric vehicle (EV) charger, the IQ® EV Charger 2, in Australia and New Zealand. The IQ EV Charger 2 is a smart charger built to work seamlessly with Enphase solar and battery systems or as a powerful standalone charger. With advanced energy management features, the charger can support increased solar self-consumption, lower energy costs, and offer a smart, efficient EV charging experience.

Webexpenses launch Expense Cards setting new standards for seamless spend management

From purchase to pay, an all-in-one platform to enhance control that's free for all Webexpenses users. LONDON, July 2, 2025 /PRNewswire/ -- Webexpenses, a leading...

Invivyd and Leading Researchers Form SPEAR (Spike Protein Elimination and Recovery) Study Group to Assess the Effects of Monoclonal Antibody Therapy for Long COVID...

Invivyd Forms SPEAR (Spike Protein Elimination and Recovery) Study Group with Researches to Assess Effects of Monoclonal Antibody Therapy for Long COVID

Combined Arms Continues to Combat Food Insecurity Among Veterans and Military Families

HOUSTON, July 2, 2025 /PRNewswire/ -- Combined Arms remains steadfast in its mission to fight food insecurity among veterans, active duty service members, and...

Autohome’s International English Website Launches on June 30 Building an Information Hub for Chinese Automakers Going Global

HONG KONG, July 2, 2025 /PRNewswire/ -- Autohome Inc. (NYSE: ATHM; HKEX: 2518) ("Autohome" or the "Company"), the globally leading online destination for automobile...

Empyrion Digital celebrates grand opening of KR1 Gangnam Data Centre

SEOUL, South Korea and SINGAPORE, July 2, 2025 /PRNewswire/ -- Empyrion Digital, a leading digital infrastructure platform in Asia, today announced the grand opening of...

Notified Spotlights AI and Unified IR Communications at HKIRA IR Awards Conference 2025

Notified highlights AI and unified IR communications at Hong Kong Investor Relations Award Conference 2025.

Arbele Wins Top Prize at BCIC’s 4th Annual Biomedical Pitch Competition

BOSTON, July 2, 2025 /PRNewswire/ -- Arbele Limited, a Hong Kong-based biotech company, was awarded first place at the 4th Biomedical Pitch Competition, hosted...

Everest Medicines Announces Updated Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of...

As of March 21st, 2025, longer follow-up data was collected from the ongoing Ph1b/2a study of EVER001: in Cohort 1, 11 patients completed 52...

Ebenbuild Secures Euro 2.3 Million EIC Grant to Scale Digital Twin Platform for Respiratory Health

Munich, Germany – July 2, 2025 -- Ebenbuild, a company developing personalized, AI-enabled digital twins of lungs to support clinical decisions and digital clinical trials, today announced that it has received Euro 2.3 million funding under the European Innovation Council (EIC) Accelerator program to advance its digital twin platform technology. In addition, the EIC fund will invest up to €10 million in future equity financing rounds raised by Ebenbuild. The funding will support the market launch of Twinhale, the first in silico trial software built for pulmonary drug delivery. The investment also underpins Ebenbuild’s broader platform strategy to transform respiratory care through personalized lung simulation – from drug development to mechanical ventilation optimization in critical care.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsLaunch